Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Febrile Encephalopathy (Phase 2)
Adrenoleukodystrophy (Phase 1)
Anemia, Aplastic (Phase 1)
Anemia, Diamond-Blackfan (Phase 1)
Crohn Disease (Phase 2)
Diabetic Foot (Phase 2)
Erectile Dysfunction (Phase 1)
Fucosidosis (Phase 1)
Gaucher Disease (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 1)
Hepatitis B, Chronic (Phase 1/Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Infarction, Posterior Cerebral Artery (Phase 2)
Intestinal Neoplasms (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Leukodystrophy, Globoid Cell (Phase 1)
Leukodystrophy, Metachromatic (Phase 1)
Meningomyelocele (Phase 1/Phase 2)
Mucopolysaccharidosis I (Phase 1)
Mucopolysaccharidosis VI (Phase 1)
Myelodysplastic Syndromes (Phase 1)
Neuronal Ceroid-Lipofuscinoses (Phase 1)
Niemann-Pick Diseases (Phase 1)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 1/Phase 2)
Penile Induration (Phase 1)
Peripheral Arterial Disease (Phase 2)
Radiation Oncology (Phase 1)
Spinal Cord Compression (Phase 2)
Stem Cells (Phase 2)
Stroke (Phase 2)
Wolman Disease (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue